Q Bio News

This is selected news for Q Bio, which is filed under Sectors / Healthtech. There are 112 news items for this page. A press release filter page is also available for Q Bio.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
11/14/2022 Q BIOMED ANNOUNCES ADDITION OF MULTI-MILLION DOLLAR ASSET VALUE WITH EQUITY STAKE IN MANIIN RESEARCH INC.
Company converts future royalty into 15% equity in multi-billion dollar potential product portfolio with additional $20M royalty NEW YORK , Nov. 14, 2022 /PRNewswire/ -- Q BioMed Inc. ( QBIO ), Q BioMed Inc. ( QBIO ), a commercial stage biotechnology acceleration development company, is pleased to announce that it has converted its long-term ...
PR Newswire
11/14/2022 Q BioMed acquires 15% of Mannin Research - Private Capital Journal
CPE News (11.14.2022) ‚Ai Q BioMed Inc. (OTCQB: QBIO) has converted its long-term royalty agreement into an equity stake in Mannin Research Inc. (MRI), a Toronto based biotechnology company. On October 29, 2015, Q BioMed entered into a US $30 million Patent and Technology License and Purchase Option Agreement ...
privatecapitaljournal.com
11/13/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Up 246.9% in October - Slater Sentinel
Q BioMed Inc. ( OTCMKTS:QBIO ‚Ai Get Rating ) was the target of a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 82,900 shares, an increase of 246.9% from the October 15th total of 23,900 shares. Based on an average ...
slatersentinel.com
11/13/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Up 246.9% in October
Q BioMed Inc. ( OTCMKTS:QBIO ‚Ai Get Rating ) saw a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 82,900 shares, an increase of 246.9% from the October 15th total of 23,900 shares. Based on an average daily volume of ...
rivertonroll.com
11/13/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update - Financial News Live
Q BioMed Inc. (OTCMKTS:QBIO ‚Ai Get Rating) was the recipient of a large increase in short interest in October. As of October 31st, there was short interest totalling 82,900 shares, an increase of 246.9% from the October 15th total of 23,900 shares. Based on an average daily trading volume ...
finnewslive.com
11/11/2022 Autism Spectrum Disorder Treatment Market Business overview 2022, and Forecast to 2030 | By -Q BioMed Inc, PaxMedica, Yamo Pharmaceuticals
... the Autism Spectrum Disorder Treatment Market: The study examines the Autism Spectrum Disorder Treatment market's competitive landscape and includes data on important suppliers, including Q BioMed Inc, PaxMedica, Yamo Pharmaceuticals, Otsuka Pharmaceutical Co. Ltd, F. Hoffmann-La Roche Ltd, Curemark, LLC, Zynerba Pharmaceuticals Inc, Axial Therapeutics, Novartis AG, STALICLA ...
heraldkeeper.com
11/3/2022 Amryt Reports Q3 2022 Financial and Operational Results
... based on the Total Shareholder Return (‚AuTSR‚Au) of Amryt's NASDAQ traded common stock relative to the TSRs of the constituents that comprise the NASDAQ Biotechnology Index (the Peer Group) as of January 1, 2022. TSR for Amryt and each peer company will be measured over the period from ...
Globe Newswire
10/14/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update
Q BioMed Inc. (OTCMKTS:QBIO ‚Ai Get Rating) saw a large drop in short interest during the month of September. As of September 30th, there was short interest totalling 23,000 shares, a drop of 64.2% from the September 15th total of 64,300 shares. Based on an average daily volume of ...
com-unik.info
10/14/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update
Q BioMed Inc. (OTCMKTS:QBIO ‚Ai Get Rating) was the recipient of a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 23,000 shares, a drop of 64.2% from the September 15th total of 64,300 shares. Based on an average ...
thelincolnianonline.com
10/11/2022 Q BIOMED PROVIDES SHAREHOLDER UPDATE
Focus on Portfolio Monetization and Roll-up Strategy NEW YORK , Oct. 11, 2022 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO ), a commercial stage biotechnology acceleration development company, is pleased to provide an update to its shareholders. The focus for 2022 is to monetize the current pipeline and build a platform for ...
PR Newswire
10/11/2022 2022-10-11 | OTCQB:QBIO | Press Release | Q BioMed Inc
QBIO 8 hours ago Focus on Portfolio Monetization and Roll-up Strategy NEW YORK , Oct. 11, 2022 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology acceleration development company, is pleased to provide an update to its shareholders. The focus for 2022 is to monetize the current pipeline and ...
stockhouse.com
10/7/2022 Global Chronic Kidney Disease Drugs Market Growth Insights, Opportunities, Business Forecast To 2027
... Allena Pharmaceuticals Inc. ‚A¢ NovaTarg Therapeutics Inc. ‚A¢ KBP BioSciences Co Ltd. ‚A¢ OPKO Health Inc. ‚A¢ Les Laboratoires Servier SAS ‚A¢ Kidney Fibrosis ‚A¢ Q BioMed Inc ‚A¢ Unity Biotechnology Inc. ‚A¢ Boryung Pharmaceutical Co Ltd. ‚A¢ Taisho Pharmaceutical Holdings Co Ltd. ‚A¢ DiaMedica Therapeutics Inc. Will You Have ...
PRSync
10/1/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update - Mayfield Recorder
Q BioMed Inc. ( OTCMKTS:QBIO ‚Ai Get Rating ) saw a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 64,300 shares, a growth of 40.1% from the August 31st total of 45,900 shares. Based on an average daily trading volume ...
Mayfield Recorder
10/1/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Up 40.1% in September - The Cerbat Gem
Q BioMed Inc. ( OTCMKTS:QBIO ‚Ai Get Rating ) was the target of a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 64,300 shares, a growth of 40.1% from the August 31st total of 45,900 shares. Based on an average ...
thecerbatgem.com
10/1/2022 Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Up 40.1% in September
Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Up 40.1% in September Posted by Jeff Wilder on Oct 1st, 2022 Share on Stocktwits Q BioMed Inc. ( OTCMKTS:QBIO ‚Ai Get Rating ) was the target of a significant growth in short interest during the month of September. As of September 15th, there ...
Daily Political
9/30/2022 Head-To-Head Comparison: Qilian International Holding Group (NASDAQ:QLI) vs. Q BioMed (OTCMKTS:QBIO)
Q BioMed ( OTCMKTS:QBIO ‚Ai Get Rating ) and Qilian International Holding Group ( NASDAQ:QLI ‚Ai https://report.stocknews.com/sign-up/ticker/?ticker=QLI&lead_source=marketbeat_snra&utm_source=marketbeat_snra&utm_medium=article&utm_campaign=ticker&utm_term=QLI&utm_content=text_link ) are both small-cap medical companies, but ...
zolmax.com
9/29/2022 Short Interest in Q BioMed (OTCMKTS:QBIO) Increases By 40.1%
Q BioMed Inc. ( OTCMKTS:QBIO ‚Ai Get Rating ) saw a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 64,300 shares, a growth of 40.1% from the August 31st total of 45,900 shares. Based on an average daily volume of ...
Ticker Report
9/28/2022 Qilian International Holding Group (NASDAQ:QLI) vs. Q BioMed (OTCMKTS:QBIO) Head-To-Head Analysis - Ticker Report
Qilian International Holding Group ( NASDAQ:QLI ‚Ai Get Rating ) and Q BioMed ( OTCMKTS:QBIO ‚Ai Get Rating ) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst ...
Ticker Report
9/28/2022 Qilian International Holding Group (NASDAQ:QLI) vs. Q BioMed (OTCMKTS:QBIO) Head-To-Head Analysis
Qilian International Holding Group (NASDAQ:QLI ‚Ai Get Rating) and Q BioMed (OTCMKTS:QBIO ‚Ai Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst ...
etfdailynews.com
9/27/2022 Q BIOMED ANNOUNCES ISSUANCE OF PATENT FOR GROUNDBREAKING GDF15 BIOMARKER
Groundbreaking GDF15 biomarker may be the first single examination to accurately predict disease progression in Glaucoma The Certificate of Grant and European Patent No. 3408287 for GDF15 IN GLAUCOMA AND METHODS OF USE THEREOF NEW YORK , Sept. 27, 2022 /PRNewswire/ -- Q BioMed Inc. ( QBIO ), a commercial stage biotechnology acceleration development ...
PR Newswire
9/27/2022 Glaucoma Pipeline Assessment – FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, Therapeutic Analysis, Growth Prospects, and Key Companies by DelveInsight
... Biotherapeutics, Novaliq GmbH, Western Therapeutics, Sun Pharma Advanced Research Company, GrayBug inc., Biozeus, Ocuphire Pharma, VISUS THERAPEUTICS, Eyevensys, Skye Bioscience inc, Eyebiotech limited, Stuart Therapeutics, Q BioMed Inc., TALLC Inc., Mitotech, Cloudbreak Pharmaceutical, Cellix Bio, Galimedix Therapeutics, Isarna Therapeutics, Ripple Therapeutics, InMed Pharmaceuticals, Arctic Vision, HK inno.N, Avirmax Inc., and ...
rhodeislandchronicle.com
9/26/2022 Contrasting Qilian International Holding Group (NASDAQ:QLI) & Q BioMed (OTCMKTS:QBIO) - Stock Observer
Qilian International Holding Group ( NASDAQ:QLI ‚Ai Get Rating ) and Q BioMed ( OTCMKTS:QBIO ‚Ai Get Rating ) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, analyst recommendations, valuation and ...
thestockobserver.com
9/25/2022 Financial Analysis: Q BioMed (OTCMKTS:QBIO) & Qilian International Holding Group (NASDAQ:QLI) - Transcript Daily
Q BioMed ( OTCMKTS:QBIO ‚Ai Get Rating ) and Qilian International Holding Group ( NASDAQ:QLI ‚Ai Get Rating ) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, risk, valuation, institutional ownership, earnings, analyst recommendations and ...
transcriptdaily.com
9/25/2022 Contrasting Qilian International Holding Group (NASDAQ:QLI) & Q BioMed (OTCMKTS:QBIO)
Qilian International Holding Group ( NASDAQ:QLI ‚Ai Get Rating ) and Q BioMed ( OTCMKTS:QBIO ‚Ai https://report.stocknews.com/sign-up/ticker/?ticker=QBIO&lead_source=marketbeat_snra&utm_source=marketbeat_snra&utm_medium=article&utm_campaign=ticker&utm_term=QBIO&utm_content=text_link ) are both small-cap medical companies, but ...
theenterpriseleader.com
9/17/2022 Choose The Best Bacteria For Septic Systems -: Everything I Discovered
... picks that are the best of the best. Preview Product Score 1 Green Gobbler SEPTIC SAVER Treatment‚A¶ Buy on Amazon 2 Roebic K-570-Q Biodegradable Leach and‚A¶ Buy on Amazon 3 Roebic K-57-Q Septic System Cleaner,‚A¶ Buy on Amazon 4 One Flush Septic Tank ...
designrfix.com